Relating to patient access to prescription drugs for off-label use for COVID-19 treatment.

Introduced

In Committee

Floor

Crossed Over

Passed

Enacted

Overview Bill text 3 Compare versions History 28 Sponsors

Engrossed — · 500 words Open full page ↗

By: Paxton, et al.

S.B. No. 883

Sign in to read the full text

The document summary and details above are public. The full text is available to signed-in accounts.

Create a free account Sign in

PASSAGE PROBABILITY

3.2% Unlikely

Why this number

Stage base Passed First Chamber — base rate 22%, measured from TX's completed sessions
Momentum +4 66/100 from the pace of recorded action
Time since last action -22 543 days quiet

A transparent scoring model over stage, momentum, recency, sponsorship and recorded votes — not a trained predictor. Treat it as a way to rank attention, not as a forecast.